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Abstract: Salivaricin B (SalB) is a protein encoded by Lactobacillus salivarius M7. This protein is insensitive to proteolytic enzymes,
such as pepsin, trypsin, and chymotrypsin, but is partially sensitive to proteinase K. SalB is also stable and maintains its activity over
a range of pHs, from 3 to 9. SalB was found to be effective against many closely related lactic acid bacteria such as, L. fermentum,
L. plantarum, L. acidophilus and distantly related gram-positive bacteria, including Listeria monocytogenes, Streptococcus faecalis,
Staphylococcus aureus and Staph. epidermidis. The mode of action of SalB was obviously bactericidal, and death occurs without
bacterial lysis. The gene responsible for SalB production in L. salivarius M7 had previously been characterized.
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Lactobacillus salivarius M7 Taraf›ndan ‹fade Edilen Salivarisin B Adl›
Proteinin Karakterizasyonu
Özet: Salivarisin B (Sal B) Lactobacillus salivarius M7 taraf›ndan kodlanan bir proteindir. Bu protein pepsin, tiripsin, kimotiripsin gibi
protein parçalayan enzimlerden etkilenmemelerine ra¤men, di¤er bir protein parçalay›c› enzim olan proteinaz K’ya karfl› k›smen
duyarl›d›rlar. Sal B 3 ile 9 aras› pH yelpazesinde aktiftir. Yap›lan çal›flmalarda, Sal B’nin Lactobacillus fermentum, Lactobacillus
plantarum, ve Lactobacillus acidophilus gibi bir çok yak›n akraba bakteriler ve Listeria monocytogenes, Streptococcus faecalis,
Staphylococcus aureus, ve Staphylococcus epidermidis gibi akraba olmayan bakteriler üzerine etkili oldu¤u bulunmufltur. Sal B’nin
etki flekli bakterisidal olup ölüm hücre parçalanmadan meydana gelmektedir. Lactobacillus salivarius M7’den Sal B kodlanmas› ve
ifadesinden sorumlu genin yeri daha önce karakterize edilmifltir.
Anahtar Sözcükler: Bakteriosin, Salivarisin B, Lactobacillus salivarius M7

Introduction
The role of lactic acid bacteria (LAB) in the production
of stable fermented food products has generated an
interest in their ability to prevent bacterial spoilage. Many
LAB species produce bacteriocins or bacteriocin-like
compounds (1-4). Like nicin, they are proteinaceous
compounds that kill closely related bacteria, but may also
elicit bactericidal activity against more distantly related
bacteria (5,6). Many researchers have concentrated on
their industrial applications for the following reasons:
firstly, they or their products can be utilized as natural
food preservatives. Secondly, since they are easily
adapted to living in the gastrointestinal system, their
products can be used as probiotics. Thirdly, the genetic
determinants for bacteriocin production and immunity

can be used for strain improvement or for constructing a
vector. Lactobacillus salivarius M7 colonizes the
gastrointestinal tract of man and animals, and is
responsible for acidic changes in the digestive tract. In
this paper, we report the physiological characterization of
the Salivarisin B (SalB) protein of L. salivarius M7. The
gene responsible for SalB production in L. salivarius M7
had previously been characterized (7).

Materials and Methods
Bacterial strains and growth conditions

L. salivarius M7, L. plantarum ATCC 8014, L.
fermentum ATCC 9338 and L. acidophilus ATCC 4357
were grown anaerobically in de Man Rogosa Sharpe
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(MRS) broth (Difco, Detroit, Mich.), overnight at 37 °C.
Bacillus, Listeria, Staphylococcus and Streptococcus
strains were grown in Tryptic Soy Broth (TSB) and on TS
agar (Difco). The E. coli Dh 5α strain was grown in LuriaBertani broth at 37 °C with vigorous agitation. The
strains used are listed in Table 1.
Table 1. Bacterial strains used.
Bacterial strains

Relevant properties

Source

L. salivarius M7
L. plantarum
L. fermentum
L. acidophilus
L. monocytogenes
Strep. faecalis
Staph. aureus
Staph. epidermidis
E. coli

Wild type
Indicator strain
Indicator strain
Indicator strain
Indicator strain
Indicator strain
Indicator strain
Indicator strain
Indicator strain

Gaziantep/TNO
ATTC 8014
ATTC 9338
ATTC 4357
L2
Field Str.
ATTC 6538
Field Str.
Dh 5a

Analysis of SalB production and sensitivity
Bacteriocin activity was tested by agar-well diffusion
tests (7,8). Culture supernatants of overnight grown L.
salivarius M7 cultures were adjusted to pH 7.0 and
filtered through a 22 µm filter (Sartorius). Lawns of each
strain were prepared by inoculating 100 µl of freshly
grown cells in 35 ml of soft MRS agar at 40 °C and were
then poured into plates. The plates were allowed to
solidify for 15 min in a drying hood, and were then
incubated anaerobically for 4 h at 37 °C. Two wells were
punched in the agar, and the bottom of the wells was
sealed with a drop of soft agar. Ten microliters of the L.
salivarius M7 supernatant were dropped into the wells.
The plates were incubated anaerobically at 37 °C for at
least 18 h and were subsequently examined for a zone of
growth inhibition. Two-fold serial dilutions of the
supernatant were used for a semiquantitative assay of
bacteriocin. The titer of bacteriocin activity was defined
as the reciprocal of the highest dilution, which did not
show inhibition of the indicator strain and was expressed
in activity units per milliliter (9).
Sensitivity of SalB
Supernatants from log-phase (10 h culture) to latestationary-phase (35 h culture) were collected from batch
(non-pH-regulated) cultures of L. salivarius M7 in MRS
broth. The pH of the supernatants was initially adjusted
to various values, and subsequently heated to 100 °C.
From each sample, a 10 µl aliquot of two-fold serial
dilutions was used to determine the bacteriocin titer.
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To test sensitivity to proteolytic enzymes, the logphase and late-stationary-phase L. salivarius M7 culture
supernatants were also used. Each aliquot of 1 ml
containing 10,200 AU/ml was treated with proteinase K,
pepsin, trypsin, chymotrypsin, catalase, lipase A,
dextranase and lysosyme, respectively, at final
concentrations of 500 µg/ml (Sigma). To exclude
potential bacterial inhibition by hydrogen peroxide, the
culture supernatants were treated with catalase at a final
concentration of 100 U/ml (10).
Mode of Action of SalB
In order to analyze the mode of action of SalB and the
effect of varying pHs, cell-free, filter-sterilized and logphase L. salivarius M7 culture supernatants (5 ml
aliquots) containing 10,200 AU/ml were adjusted to pH
3.0, 4.0, 5.0, 6.5 or 7.0, and incubated at 37 °C for 30
min. A total of 200 µl of log-phase cultures of the L.
fermentum ATCC 9338, L. plantarum ATCC 8014 and L.
acidophilus ATCC 4357 were centrifuged (5000 x g, 10
min), washed in saline (0.9 NaCl, wt/vol) and
resuspended in 500 µl MRS broth. After adjusting the pH
of each aliquot of L. salivarius M7 culture supernatant to
7.0, a 25 µl aliquot containing 10,200 AU/ml was added
to each cell suspension and then incubated at 37 °C for
30 min. A 100 U/ml catalase was added to each mixture
to prevent the inhibitory effect of hydrogen peroxide.
After incubation, cells were cetrifuged (5000 x g, 10
min), washed in saline (0.9 NaCl, wt/vol) and plated on
MRS agar. As a control, 100 µl of log-phase cells of L.
fermentum ATCC 9338, L. plantarum ATCC 8014 and L.
acidophilus ATCC 4357 were inoculated into MRS broth
lacking bacteriocin activity, and the tubes were incubated
at 37 °C for 16 h (5-7).
For dose-response studies, serial dilutions of SalB
were added to 100 µl of log-phase suspensions of the L.
fermentum ATCC 9338, L. plantarum ATCC 8014 and L.
acidophilus ATCC 4357 strains and incubated for 30 min
at 37 °C (7). The samples were then centrifuged (5000 x
g, 10 min), washed in saline (0.9 NaCl, wt/vol) and
spread on MRS agar. The percentage of SalB-induced cell
death was calculated from the decrease in the number of
viable cells.
Stability of SalB
Supernatants from log-phase L. salivarius M7 cultures
were adjusted to varying pH values and heated to 100 °C
for 15 min. The treated supernatants were stored at –20
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°C, 4 °C and room temperature. At different time
intervals aliquots were taken and used to determine the
inhibitory activity.

Results
Production of SalB
Broth conditions for the production of SalB and the
growth of L. salivarius M7 were evaluated in non-pHregulated culture environments. Different initial pHs were
tested for broth conditions for the production of SalB.
Weak acidic conditions seemed to favor optimal growth
of L. salivarius M7.
When the pH of the broth was initially adjusted to
6.5, maximum production of SalB (10,240 AU/ml) was
observed (Table 2).

Table 3. Effect of pH on the activity of SalB at 37 °C.
pH

Activity development
(inhibition zone against
L. fermentum in mm)

9
8
7.5
7.0
6.5
6.0
5.5
5.0
4.5
4.0
3.5
3.0

9
9
11
13
20
15
8
8
6
6
6
6

Table 4. Sensitivity of SalB to enzymes at 37 °C.
Treatment

Diameter (mm) of
zone of inhibition against
L. fermentum

Table 2. SalB production at various pH values.
PH

AU/ml

5.0

640 AU/ml

5.5

640 AU/ml

6.0

6400 AU/ml

6.5

10,240 AU/ml

7.0

5220 AU/ml

7.5

5220 AU/ml

Effect of pH heat, and enzyme treatment on
bacteriocin activity
The effect of pH and temperature on the stability of
SalB was assessed on filtered, neutralized and heattreated active supernatants containing 10,240 AU/ml
SalB activity. At all pH values above pH 2, the activity of
the supernatant remained stable (Table 3). Storing the
supernatant under pH 3.0 for 30 min did not change the
activity. Storing it in a refrigerator for up to 3 months
and for over 20 h at pH 5.0 at room temperature also
had no effect. SalB activity was partially sensitive only to
treatment with proteinase K (Table 4). In comparison to
the activity of proteinase K, SalB activity was tested both
with phosphate buffer saline (15-20 mm of zone of
inhibition), and with proteinase K: the latter was found to
decrease the SalB activity by 15% (8 mm of zone of
inhibition). SalB was also found to be stable under heat
treatment (Table 5).

Control (phosphate buffer)
Trypsin
Chymotrypsin
Pepsin
Trypsin
Proteinase K
Lipase A
Lysozyme
Catalase

15
15
14
14
14
9
15
14
17

Table 5. Sensitivity of SalB to temperature.
Treatment

Diameter of the
inhibition zone
(in mm)activity

Proteinase K
(%)

15
15
8
15
14
14
12

0
0
15
0
10
5
5

Control (no heat)
60 °C for 30 min
60 °C for 60 min
75 °C for 30 min
75 °C for 60 min
100 °C for 15 min
121 °C for 15 min

*The diameter of the well is not included in the inhibition zone.
*The data represent the diameter of the inhibition zone (in mm)
obtained with the agar diffusion test.

Inhibition spectrum
Analysis of the inhibition spectrum of SalB using the
agar-well diffusion test showed that this bacteriocin
inhibited the growth of a variety of closely related
bacteria (Table 6). These include L. fermentum ATCC
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Table 6. Inhibition of lactobacilli by culture supernatant fluid of L.
salivarius M7.
Target organism

Code numbers

L. acidophilus

ATCC 4357

> 15

L. fermentum

ATCC 9338

> 15

L. plantarum

ATCC 8014

> 15

L. monocytogenes

L2*

> 15

Staph. aureus

ATCC 6538

3-5

Staph. epidermidis

*

15

Strep. faecalis

*

10

decline in the viability of LAB strains was observed in the
first minutes of contact with SalB at all pH values > 2.0.
The optical density at 590 nm did not change at any pH
values for LAB strains and L. monocytogenes during 20 h
of incubation. At the end of each trial, a 100 µl sample of
the indicator strains was plated on agar and allowed to
grow at 37 °C for 16 h. Plate counts were performed,
and the number of viable cells at each trial was found to
decrease substantially (Table 7). A zone of growth
inhibition was observed for all LAB strains and L.
monocytogenes L2 starting from 1 µl of supernatant
containing 50 AU/mL. However, when the same trials
were applied to Strep. faecalis, there was a slow decline
in OD, and there was also growth on the agar. When the
concentration of SalB in the medium was ≥ 5000 AU/ml,
the growth of Strep. faecalis was substantially impaired.
A concentration of 10,000 AU/ml or more was
insufficient to kill Staph. epidermidis and Staph. aureus
ATCC 6538.

Zone diameter

* Strain from field isolates.
The diameter of the well is not included in the inhibition zone.
The data represent the diameter of the inhibition zone (in mm)
obtained with the agar diffusion test.

9338, L. plantarum ATCC 8014, L. acidophilus ATCC
4357 and some more distantly related bacteria such as,
L. monocytogenes L2, Strep. faecalis, Staph. epidermidis
and Staph. aureus ATCC 6538. SalB was very effective
against all the L. monocytogenes strains tested. Staph.
aureus was not affected when the amount of active SalB
was less than 10,000 AU/mL.

The decrease in the number of viable cells indicated
that no lysis of the indicator strain occurred since there
was no change in the OD of the medium via UV
spectroscopy. Plate counting of the indicator strains
treated with the various doses of SalB also clearly
indicated that as the dose of bacteriocin increased, the
number of dead indicator cells also rose.

Bactericidal action of SalB
To characterize the mode of action of SalB, the
viability of the indicator strains L. fermentum ATCC
9338, L. plantarum ATCC 8014, L. acidophilus ATCC
4357 and L. monocytogenes L2 were monitored in the
presence of different concentrations of SalB (Table 6).
Starting from 1 µl of 50 AU/ml supernatant, a rapid

Discussion
SalB, a bacteriocin produced by L. salivarius M7, was
physiologically characterized. Its genetic characterization

Table 7. Effect of SalB on the death of LAB species and L. monocytogenes.

SalB (AU)

Colony count

Cell death (%)

Strain

0

2.6 x 109

0

L. acidophilus ATCC 4357

0

2.9 x 108

0

L. monocytogenes L2

8

50

2.7 x 10

68.9

L. monocytogenes L2

50

2.9 x 108

88.84

L. acidophilus ATCC 4357

8

2.1 x 10

91.92

L. acidophilus ATCC 4357

2.2 x 108

24.13

L. monocytogenes L2

2600

6

3.3 x 10

99.87

L. acidophilus ATCC 4357

2.600

3.7 x 107

87.24

L. monocytogenes L2

10.240

2

1.2 x 10

99.99

L. acidophilus ATCC 4357

10.240

1.8 x 106

99.03

L. monocytogenes L2

5.00
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had been completed previously (11). Neither the
production of SalB nor the activity of the protein were
found to be affected by the pH of the medium. L.
salivarius M7 grew better under weak acid conditions,
although it also grew and produced SalB between pH 3.0
and 9.0. Production, depending on cell density, started as
early as 4 h and continued to 10 h of growth. The activity
of the protein did not seem to change over 20 h after
storage at room temperature, or 3 months at 4 °C. SalB
was highly stable during heating, and during repeated
freezing and thawing cycles was resistant to 100 °C for
30 min. and 121 °C for 15 min. The stability properties
were similar to those of the bacteriocins, such as lactacin
B and F, produced by L. acidophilus (12,13). SalB was
active in the presence of many proteolytic enzymes
including trypsin, chymotrypsin and lysozyme, lipolytic
enzymes such as lipase A, and glucolytic enzymes such as
dextranase, but was partially sensitive to proteinase K.
These results suggest that the antibactericidal compound
was indeed a protein in nature and that lipidic and glucidic
moieties are absent in its structure or are not required for
its biological activity. SalB was active against many closely
related LAB strains, including L. fermentum ATCC 9338,
L. plantarum ATCC 8014 and L. acidophilus ATCC 4357,
and against many more distantly related Gram-positive
bacteria such as L. monocytogenes L2, Strep. faecalis,
Staph. epidermidis and Staph. aureus ATCC 6538. SalB
has no inhibitory activity on Gram-negative bacteria and
B. cereus. The time course of SalB activity against L.
fermentum ATCC 9338, L. plantarum ATCC 8014 and L.
monocytogenes L2 was not always parallel in non-pHregulated MRS broth cultures. For example, the MRS
broth culture of L. salvarius M7 initially adjusted to pH
6.5 and non-regulated throughout the experiment
provided a higher titer than the culture of MRS broth
adjusted to 7.0, 7.5 or 6.0 initially. With subcultures of
L. salivarius M7 in MRS agar instead of in broth, there
was no bacterial growth, which may indicate an
intracellular induction factor. As described for most
bacteriocins produced by LAB (11-16), SalB exhibits a
bactericidal mode of action against sensitive cells in the
log-phase of growth. This is reminiscent of ion-channelforming bacteriocins, which require the presence of a
transmembrane potential or a pH gradient to be active.
Therefore, they are far more active on log-phase cells
than on stationary-phase cells. The kinetic data have
indicated that bacteriocins behave as a single lethal entity

in a single hit process. Killing of sensitive cells by SalB
occurred within a few minutes (for all LAB strains, L.
monocytogenes L2 and other L. monocytogenes field
strains), and the threshold dose against LAB strains and
L. monocytogenes L2 was 50 AU/mL. For Staph.
epidermidis and Staph. aureus, the threshold dose is over
5000 AU/ml, and for Strept. faecalis it is over 300
AU/mL. These differences reinforced suggestions that
SalB may act in a single hit fashion (4, 9) since treatment
of the exponential phase indicator cells with SalB resulted
in the death of cells, with the percentage of cell death
increasing with the amount of bacteriocin added.
Interestingly, the bactericidal effect and stability of SalB
occurred at pH 3.0 to 9.0. The effectiveness of
bacteriocin depends on both its concentration and the
bacteria producing it.
Thus, while SalB belongs to the class II LAB
bacteriocins it is not homologous to bacteriocins of the
anti-listeria family. The primary structure of the
predicted translational product of the SalB structural
gene indicates that SalB is synthesized as a precursor
protein (1). In addition to acidification, SalB also has a
strong anti-listerial activity. Therefore, both the
bacterium and its products are good candidates for the
restoration of a digestive system that is disorganized by
pathogenic bacteria.
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